1. [Molecular genetic diagnosis of Stargardt disease].
- Author
-
Sheremet NL, Zhorzholadze NV, Ronzina IA, Grushke IG, Kurbatov SA, Chukhrova AL, Loginova AN, Shcherbakova PO, Tanas AS, Polyakov AV, and Strel'nikov VV
- Subjects
- Adolescent, Adult, Child, Female, Genetic Predisposition to Disease, Genetic Testing methods, High-Throughput Nucleotide Sequencing methods, Humans, Macular Degeneration diagnosis, Macular Degeneration genetics, Male, Mutation, Polymorphism, Single Nucleotide, Rod Cell Outer Segment pathology, Russia, Stargardt Disease, ATP-Binding Cassette Transporters genetics, Macular Degeneration congenital
- Abstract
Aim: To comparatively evaluate the efficacy of genetic screening in patients with Stargardt disease (SD) by using an express panel of 5 most common ABCA4 mutations and performing massive parallel sequencing of all coding regions of the ABCA4, ELOVL4, PROM1, and CNGB3 genes., Material and Methods: MLPA analysis for 5 ABCA4 mutations, namely p.G863A, p.L541P, p.A1038V, p.G1961E, and p.P1380L, was done in 54 patients with SD. In 25 patients, massive parallel sequencing of coding regions (exons) and neighboring introns of the ABCA4, ELOVL4, PROM1, and CNGB3 genes was also performed., Results: Gene testing for 5 ABCA4 mutations showed that 50% of patients (27 patients) harbored one mutation and 13% - two mutations. At massive parallel sequencing (25 patients), two pathogenic alleles were found in 21 patients (84%), one mutation - in 23 patients (91.7%). The majority of mutations was accounted for by the ABCA4 gene (83% of all mutation-positive patients)., Conclusion: Sequencing of exons and neighboring introns of the ABCA4, ELOVL4, PROM1, and CNGB3 genes with the new molecular genetic diagnostic system enabled confirmation of the diagnosis of SD in 84% of patients. High prevalence of p.L541P, p.A1038V, and p.G1961E mutations of the ABCA4 gene has been established.
- Published
- 2017
- Full Text
- View/download PDF